Acrobiosystems for English
icon_bulk_orderAnfrage Sammelbestellung/Schnellbestellung
user
  1. Übersicht
  2. Mein Profil
  3. Meine Adresse
  4. Meine Bestellungen
  5. Acro-Mitgliedschaft
Login Registrieren
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
Es befinden sich keine Waren im Warenkorb !
Mein Warenkorb|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > CXCR3

CXCR3

Brief Information

Name:C-X-C motif chemokine receptor 3
Target Synonym:CKR-L2,G protein-coupled receptor 9,IP-10 receptor,CXCR-3,CXC-R3,CXCR3,C-X-C Motif Chemokine Receptor 3,Interferon-Inducible Protein 10 Receptor,GPR9,C-X-C Chemokine Receptor Type 3,Chemokine Receptor 3,CD183 Antigen,CMKAR3,Chemokine (C-X-C Motif) Receptor 3,Mig Receptor,IP10-R,CD182,CD183,Mig-R,MigR,Receptors, CXCR3
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Product> Filter Results
Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
CX3-M52P7 Mouse Mouse CXCR3 Full Length Protein (VLP)
CX3-H52D5 Human Human CXCR3 Protein, Flag,His Tag (Detergent)
CX3-H52D5-structure
CX3-H52P4 Human Human CXCR3 Full Length Protein (VLP)
ACRO Quality

Part of Bioactivity data

CX3-H52P4-SPR
CXCR3 SPR

Anti-CXCR3 antibody immobilized on CM5 Chip can bind Human CXCR3 Full Length Protein-VLP (Cat. No. CX3-H52P4) with an affinity constant of 60.9 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol
CX3-H52D5-ELISA
CXCR3 ELISA

Immobilized Human CXCR3 Protein, Flag,His Tag (Cat. No. CX3-H52D5) at 1 μg/mL (100 μL/well) can bind Anti-CXCR3 Antibody, Human IgG1 with a linear range of 0.03-1 ng/mL (QC tested).

Protocol

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
OCU-110 OCU-110; OCU-10-C-110 Phase 1 Clinical Ocugenix Corp Macular Degeneration Details
ACT-777991 ACT-777991 Phase 1 Clinical Idorsia Pharmaceuticals Ltd Inflammation Details
OCU-110 OCU-110; OCU-10-C-110 Phase 1 Clinical Ocugenix Corp Macular Degeneration Details
ACT-777991 ACT-777991 Phase 1 Clinical Idorsia Pharmaceuticals Ltd Inflammation Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
E-Mail
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Nachricht schicken

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap